Clinical Trials
5 trialsNCT07616141 2026-06-01
NAET4-SNACC
Eye & ENT Hospital of Fudan University
Phase 2 Not yet recruiting
NCT05582499 2026-05-28
FASCINATE-N
Fudan University
Phase 2 Recruiting
NCT07612098 2026-05-28
SPARE-04
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT07602101 2026-05-22
Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma
RenJi Hospital
Phase 2 Not yet recruiting
NCT05301764 2026-05-20
A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma
Lyvgen Biopharma Holdings Limited
Phase 1/2 Completed